Chua N - Search Results

1

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.

Villa D, George A, Seymour JF, Toze CL, Crump M, Lee C, Buckstein R, Stewart DA, MacDonald D, Foley R, Xenocostas A, Sabloff M, Chua N, Couture F, Larouche JF, Cohen S, Savage KJ, Connors JM, Panzarella T, Carney DA, Dickinson M, Kuruvilla J. Villa D, et al. Among authors: chua n. Biol Blood Marrow Transplant. 2014 Nov;20(11):1813-8. doi: 10.1016/j.bbmt.2014.07.015. Epub 2014 Jul 18. Biol Blood Marrow Transplant. 2014. PMID: 25042735 Free article.

2

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma.

Dueck G, Chua N, Prasad A, Finch D, Stewart D, White D, van der Jagt R, Johnston J, Belch A, Reiman T. Dueck G, et al. Among authors: chua n. Cancer. 2010 Oct 1;116(19):4541-8. doi: 10.1002/cncr.25377. Cancer. 2010. PMID: 20572046 Free article. Clinical Trial.

3

A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).

Kouroukis CT, Fernandez LA, Crump M, Gascoyne RD, Chua NS, Buckstein R, Turner R, Assouline S, Klasa RJ, Walsh W, Powers J, Eisenhauer E. Kouroukis CT, et al. Leuk Lymphoma. 2011 Mar;52(3):394-9. doi: 10.3109/10428194.2010.546015. Leuk Lymphoma. 2011. PMID: 21323520 Clinical Trial.

4

Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.

Buckstein R, Kuruvilla J, Chua N, Lee C, Macdonald DA, Al-Tourah AJ, Foo AH, Walsh W, Ivy SP, Crump M, Eisenhauer EA. Buckstein R, et al. Among authors: chua n. Leuk Lymphoma. 2011 May;52(5):833-41. doi: 10.3109/10428194.2011.555892. Epub 2011 Apr 4. Leuk Lymphoma. 2011. PMID: 21463120 Free PMC article. Clinical Trial.

5

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA, MacDonald DA, Buckstein R, Lee C, Alzahrani M, Rubinger M, Foley R, Xenocostas A, Sabloff M, Muccilli A, Chua N, Couture F, Larouche JF, Cohen S, Connors JM, Ambler K, Al-Tourah A, Ramadan KM, Kuruvilla J. Villa D, et al. Among authors: chua n. J Clin Oncol. 2013 Mar 20;31(9):1164-71. doi: 10.1200/JCO.2012.44.0693. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401459

6

Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis.

Oh DH, Ghosh S, Chua N, Kostaras X, Tilley D, Chu M, Owen CJ, Stewart DA. Oh DH, et al. Among authors: chua n. Leuk Lymphoma. 2015 Jun;56(6):1756-62. doi: 10.3109/10428194.2014.971409. Epub 2014 Nov 3. Leuk Lymphoma. 2015. PMID: 25284495

7

Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant.

Oh DH, Chua N, Street L, Stewart DA. Oh DH, et al. Among authors: chua n. Leuk Lymphoma. 2016;57(1):28-33. doi: 10.3109/10428194.2015.1026901. Epub 2015 Mar 27. Leuk Lymphoma. 2016. PMID: 25747968

8

Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy.

Chu MP, Lieffers J, Ghosh S, Belch AR, Chua NS, Fontaine A, Sangha R, Turner AR, Baracos VE, Sawyer MB. Chu MP, et al. PLoS One. 2015 Jun 1;10(6):e0127589. doi: 10.1371/journal.pone.0127589. eCollection 2015. PLoS One. 2015. PMID: 26030144 Free PMC article.

9

Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis.

Oh DH, Li H, Duan Q, Villa D, Peters A, Chua N, Owen CJ, Connors JM, Stewart DA. Oh DH, et al. Among authors: chua n. Biol Blood Marrow Transplant. 2016 May;22(5):941-8. doi: 10.1016/j.bbmt.2016.01.015. Epub 2016 Jan 16. Biol Blood Marrow Transplant. 2016. PMID: 26785331 Free article. Clinical Trial.

10

Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.

Chu MP, Lieffers J, Ghosh S, Belch A, Chua NS, Fontaine A, Sangha R, Turner RA, Baracos VE, Sawyer MB. Chu MP, et al. J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):298-304. doi: 10.1002/jcsm.12161. Epub 2016 Nov 21. J Cachexia Sarcopenia Muscle. 2017. PMID: 27897411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters